NASDAQ:IBBQ Invesco Nasdaq Biotechnology ETF (IBBQ) Price, Holdings, & News → Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad) Free IBBQ Stock Alerts $20.52 -0.26 (-1.25%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$20.36▼$20.8050-Day Range$20.28▼$22.9852-Week Range$18.18▼$23.02Volume5,267 shsAverage Volume20,243 shsMarket Capitalization$30.16 millionAssets Under Management$30.52 millionDividend Yield0.88%Net Expense Ratio0.19% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Get Invesco Nasdaq Biotechnology ETF alerts: Email Address About Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.Read More IBBQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBBQ ETF News HeadlinesApril 1, 2024 | msn.comQQQ ETF Update, 4/1/2024February 27, 2024 | markets.businessinsider.comVestmark In Partnership With Invesco On Portfolio SolutionsApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.January 10, 2024 | markets.businessinsider.comAnalyst Expectations For Invesco's FutureJanuary 9, 2024 | msn.comBiotech ETFs Stage Solid Comeback at the Start of 2024December 20, 2023 | msn.comInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.0526December 4, 2023 | msn.comInvesco Advisors completes IHIT termination and liquidationNovember 1, 2023 | investing.comSBIO ETF Stock Price HistoryApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.October 23, 2023 | msn.comInvesco BulletShares 2029 Corporate Bond ETF declares monthly distribution of $0.0621See More Headlines Receive IBBQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerInvesco Fund NameInvesco Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBBQ Inception Date6/11/2021 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Previous SymbolNASDAQ:IBBQ WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings220 Fund Statistics Assets Under Management$30.52 million Average Daily Volume$0.00 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerLatour Trading Miscellaneous Outstanding Shares1,470,000Beta0.61 Creation Unit10,000 Creation Fee$600.00 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 Invesco Nasdaq Biotechnology ETF ExpensesTypeIBBQHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.19%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.19%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%Net Expense0.19%0.60%0.60%0.54%0.58% Invesco Nasdaq Biotechnology ETF (IBBQ) Holdings & ExposureTop 10 IBBQ HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 8.68%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 8.28%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 8.22%Gilead Sciences(NASDAQ:GILD)Holding Weight: 8.18%AstraZeneca(NASDAQ:AZN)Holding Weight: 4.51%Moderna(NASDAQ:MRNA)Holding Weight: 4.37%Biogen(NASDAQ:BIIB)Holding Weight: 3.19%Illumina(NASDAQ:ILMN)Holding Weight: 2.10%Alnylam Pharmaceuticals(NASDAQ:ALNY)Holding Weight: 2.05%BioMarin Pharmaceutical(NASDAQ:BMRN)Holding Weight: 1.89%IBBQ Sector ExposureIBBQ Industry ExposureFull Holdings Details Similar ETFsPrincipal Healthcare Innovators ETFNASDAQ:BTECFirst Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHHorizon Kinetics Medical ETFNASDAQ:MEDXJPMorgan Healthcare Leaders ETFNASDAQ:JDOCProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISInstitutional OwnershipEudaimonia Advisors LLCBought 70,693 shares on 4/25/2024Ownership: 4.809%Eudaimonia Partners LLCBought 41,612 shares on 4/25/2024Ownership: 2.831%View All Institutional Transactions IBBQ ETF - Frequently Asked Questions How have IBBQ shares performed in 2024? Invesco Nasdaq Biotechnology ETF's stock was trading at $21.89 at the start of the year. Since then, IBBQ stock has decreased by 6.3% and is now trading at $20.52. View the best growth stocks for 2024 here. Are investors shorting Invesco Nasdaq Biotechnology ETF? Invesco Nasdaq Biotechnology ETF saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 25,700 shares, an increase of 213.4% from the March 31st total of 8,200 shares. Based on an average trading volume of 18,100 shares, the short-interest ratio is presently 1.4 days. View Invesco Nasdaq Biotechnology ETF's Short Interest. How often does Invesco Nasdaq Biotechnology ETF pay dividends? What is the dividend yield for Invesco Nasdaq Biotechnology ETF? Invesco Nasdaq Biotechnology ETF announced a quarterly dividend on Friday, March 15th. Shareholders of record on Tuesday, March 19th will be given a dividend of $0.0435 per share on Friday, March 22nd. This represents a $0.17 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date of this dividend is Monday, March 18th. Read our dividend analysis for IBBQ. What does IBBQ invest in? Invesco Nasdaq Biotechnology ETF is a equity fund issued by Invesco. IBBQ focuses on health care investments and follows the Nasdaq Biotechnology Index. The fund's investments total to approximately $30.52 million assets under management. What stocks does Invesco Nasdaq Biotechnology ETF hold? IBBQ invests in 220 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), AstraZeneca (AZN), Moderna (MRNA), Biogen (BIIB), Illumina (ILMN), Alnylam Pharmaceuticals (ALNY) and BioMarin Pharmaceutical (BMRN). What is the management fee for Invesco Nasdaq Biotechnology ETF? Invesco Nasdaq Biotechnology ETF's management fee is 0.19% and has no other recorded expenses or fee waivers. The net expense ratio for IBBQ is 0.19%. Who are Invesco Nasdaq Biotechnology ETF's major shareholders? Invesco Nasdaq Biotechnology ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include Eudaimonia Advisors LLC (4.81%) and Eudaimonia Partners LLC (2.83%). How do I buy shares of Invesco Nasdaq Biotechnology ETF? Shares of IBBQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IBBQ) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
